Celeste Mellet
Known title: Chief Financial OfficerCIK: 0001748812
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Goldman Sachs lowers Evercore price target to $331. Goldman Sachs maintained its positive stance on Evercore but reduced its price target to $331. Separately, Evercore noted that the risk of a yield-curve inversion is increasing while the AI-driven market rally continues. The stock currently trades near its support level, with an average analyst target of $359.30.
Transaction History
| HUM | ▲ Buy | Grant | 15,387 | $0 | 5/1/2026 | View on chart |
| HUM | ▲ Buy | Option Exercise | 7,763 | $0 | 2/13/2026 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 4,204 | $763K | 2/13/2026 | View on chart |
| HUM | ▼ Sell | Tax Withholding | 1,222 | $330K | 12/15/2025 | View on chart |
| HUM | ▲ Buy | Option Exercise | 2,128 | $0 | 12/15/2025 | View on chart |
| HUM | ▲ Buy | Grant | 6,385 | $0 | 2/24/2025 | View on chart |
| HUM | ▲ Buy | Grant | 23,291 | $0 | 2/13/2025 | View on chart |
| EVR | ▼ Sell | Tax Withholding | 2,715 | $250K | 7/6/2022 | View on chart |
| EVR | ▲ Buy | Grant | 16,574 | $0 | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Humana to drop 37 PPOs for 2027 Medicare Advantage plans
Humana announced it will discontinue 37 Preferred Provider Organization (PPO) plans for the 2027 Medicare Advantage enrollment period. The company noted that affected members may qualify for a Medigap open enrollment window without health questions. This structural change impacts the company's product lineup and member retention strategies for the upcoming year.
Humana to drop 37 PPOs for 2027 Medicare Advantage plans. Humana announced it will discontinue 37 Preferred Provider Organization (PPO) plans for the 2027 Medicare Advantage enrollment period. The company noted that affected members may qualify for a Medigap open enrollment window without health questions. This structural change impacts the company's product lineup and member retention strategies for the upcoming year.